HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension?

AbstractOBJECTIVE:
The human kidney-specific chloride channels ClC-Ka (rodent ClC-K1) and ClC-Kb (rodent ClC-K2) are important determinants of renal function, participating to urine concentration and blood pressure regulation mechanisms. Here we tested the hypothesis that these chloride channels could represent new drug targets for inducing diuretic and antihypertensive effects.
METHODS:
To this purpose, the CLC-K blockers benzofuran derivatives MT-189 and RT-93 (10, 50, 100 mg/kg), were acutely administered by gavage in Wistar rats, and pharmacodynamic and pharmacokinetic parameters determined by functional, bioanalytical, biochemical and molecular biology assays.
RESULTS:
Plasma concentration values for MT-189 and RT-93 were indicative of good bioavailability. Both MT-189 and RT-93 dose-dependently increased urine volume without affecting electrolyte balance. A comparable reduction of SBP was observed in rats after MT-189, RT-93 or furosemide administration. Benzofuran derivatives treatment did not affect kidney CLC-K mRNA level or inner medulla osmolality, whereas a significant vasopressin-independent down-regulation of aquaporin water channel type 2 was observed at protein and transcriptional levels. In rats treated with benzofuran derivatives, the observed polyuria was mainly water diuresis; this finding indirectly supports a cross-talk between chloride and water transport in nephron. Moreover, preliminary in-vitro evaluation of the drugs capability to cross the blood-inner ear barrier suggests that these compounds have a limited ability to induce potential auditory side effects.
CONCLUSION:
CLC-K blockers may represent a new class of drugs for the treatment of conditions associated with expanded extracellular volume, with a hopeful high therapeutic potential for hypertensive patients carrying ClC-K gain-of-function polymorphisms.
AuthorsAntonella Liantonio, Gianluca Gramegna, Giulia M Camerino, Maria M Dinardo, Antonia Scaramuzzi, Maria A Potenza, Monica Montagnani, Giuseppe Procino, Domenica R Lasorsa, Lisa Mastrofrancesco, Antonio Laghezza, Giuseppe Fracchiolla, Fulvio Loiodice, Maria G Perrone, Angela Lopedota, Salvatore Conte, Rosa Penza, Giovanna Valenti, Maria Svelto, Diana Conte Camerino
JournalJournal of hypertension (J Hypertens) Vol. 30 Issue 1 Pg. 153-67 (Jan 2012) ISSN: 1473-5598 [Electronic] England
PMID22080226 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chloride Channels
  • Water
Topics
  • Animals
  • Blood Pressure
  • Blotting, Western
  • Chloride Channels (antagonists & inhibitors)
  • Diuresis
  • Hypertension (metabolism, physiopathology)
  • Rats
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Spectrometry, Mass, Electrospray Ionization
  • Water

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: